Article Text

Download PDFPDF
Letter
Hospital pharmacist role in an autoimmune disease unit: an opportunity for improvement
  1. Virginia Martínez-Santana1,
  2. Julia Barbado-Ajo2,
  3. Teresa Sánchez-Sánchez1,
  4. Mercedes Fernández-Prieto1
  1. 1Department of Pharmacy, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
  2. 2Department of Internal Medicine, Autoimmune Disease Unit, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
  1. Correspondence to Virginia Martínez Santana, Department of Pharmacy, Hospital Clínico Universitario de Valladolid, C/Ramón y Cajal, 3, Valladolid 47003, Spain; vmartinez1{at}hotmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

During the past 50 years, healthcare has progressed enormously, improving the health and quality of life of patients. The reasons are many but the contribution of pharmacists has played an important role.1

Patients with autoimmune diseases are subject to multiple and complex chronic treatments. A large proportion of patients do not respond to treatment, lose response to treatment, do not tolerate or have adverse reactions to treatment. Therefore, the activity of the pharmacist in the autoimmune disease unit would be an opportunity to improve the health of patients.

In this kind of unit the establishment of prevention of adverse reactions systems should be suggested as …

View Full Text

Footnotes

  • Contributors VM-S: conception and design; JB-A, TS-S and MFz-P: drafting the article or revising it critically for important intellectual content. TS-S: final approval of the version to be published.

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • Editorial
    Per Hartvig Honoré